A Phase III Study to Test the Benefit of a New Kind of Anti-cancer Treatment in Patients With Melanoma, After Surgical Removal of Their Tumor

NCT00796445 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
1351
Enrollment
INDUSTRY
Sponsor class

Stopped The study was terminated early following assessment of the two co-primary endpoints showing the lack of efficacy of the study product.

Conditions

Interventions

Sponsor

GlaxoSmithKline